1. Home
  2. UHT vs VALN Comparison

UHT vs VALN Comparison

Compare UHT & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Health Realty Income Trust

UHT

Universal Health Realty Income Trust

HOLD

Current Price

$38.56

Market Cap

561.5M

Sector

Real Estate

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.23

Market Cap

653.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UHT
VALN
Founded
1986
2012
Country
United States
France
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
561.5M
653.3M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
UHT
VALN
Price
$38.56
$6.23
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
★ $43.00
$15.50
AVG Volume (30 Days)
★ 82.8K
28.1K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
★ 7.33%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.79
N/A
Revenue
★ $99,190,000.00
N/A
Revenue This Year
$2.12
N/A
Revenue Next Year
$2.94
$93.87
P/E Ratio
$48.96
★ N/A
Revenue Growth
★ 0.18
N/A
52 Week Low
$35.26
$4.75
52 Week High
$46.30
$12.23

Technical Indicators

Market Signals
Indicator
UHT
VALN
Relative Strength Index (RSI) 32.06 40.11
Support Level $38.11 $5.10
Resistance Level $40.90 $6.42
Average True Range (ATR) 0.77 0.20
MACD -0.20 -0.10
Stochastic Oscillator 10.94 9.04

Price Performance

Historical Comparison
UHT
VALN

About UHT Universal Health Realty Income Trust

Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: